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Editorial
Welcome to the fourth issue of The British Student Doctor.
In this issue, we feature ‘The case of the vanishing medical student’ by Henry Dunn, a 
medical student at King’s College London, and his colleagues Thomas Taylor and 
Amanda Bacon, medical students at the University of Oxford. In this reflective piece, 
they discuss how medical students are failing to take full opportunity of clinical 
placements. The authors believe that this is due to a number of factors, including the 
limited availability of bedside teaching, a culture of not wishing to overburden busy 
junior doctors, and a perception that there is little to gain from so called ‘ward work’. 
As medical students, we also experienced the same challenges during our clinical 
attachments; being encouraged to study textbooks rather than to spend time on 
clinical placements or to ‘take advantage’ of our free time whilst we could before 
facing the pressures of life in the NHS. Now as junior doctors at the end of our 
foundation year, reflecting back on the issues raised by Dunn et al., we understand 
these perceptions. However, we also realise with new insight the importance of using 
clinical practice to gain as much preparation as possible before the transition from 
medical student to junior doctor. Having passed through this phase recently, the 
change in responsibility that this passage entails cannot be underestimated. 
Sir William Osler, a Canadian physician who founded John Hopkins Hospital in 
Baltimore, Maryland, and was the pioneer of bedside teaching, wrote in his book 
Aequanimitas in 1904: 
“He who studies medicine without books sails an uncharted sea, but he who studies medicine 
without patients does not go to sea at all.”
When under pressure as junior doctors, often during the middle of the night on a 
busy ward cover shift, it is not the textbooks that we remember, but the patients that 
we have encountered as medical students on clinical attachments. These experiences 
serve as the guidance that we need to manage the most difficult of situations, and 
even to find solace in during the most stressful of times. However, we also realise 
that we now hold a responsibility to optimise the experience of medical students in 
our hospitals, to ensure that they do not feel undervalued or burdensome. It is also 
our responsibility to act as role models for the students that we teach, and stress the 
value of clinical attachments. 
In this issue of The British Student Doctor, we also feature research by Andy Cheng 
and his colleagues on ‘Analysing ethnic differences in compulsory admissions for psychiatric 
disorders in the UK’. This pertinent work reveals worse outcomes for persons of ethnic 
minority backgrounds. 
This issue also features a number of education articles, including ‘Cannabis – current 
trends and methods of bioavailability’ by Sarah Gritis, ‘The Ponseti method for the treatment of 
congenital talipes equinovarus’, ‘Recent advances in the understanding of non-coding RNA’ by 
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Jernej Zorman and ‘Skin picking disorders – what can we learn from such a topical issue?’ by 
George Johnson and colleagues. 
Finally, we also publish an article by Luke Roberts and his colleagues at the Evelina 
London Children’s Hospital on the topic of clinical coding. This article provides a rare 
insight into a process which is considered esoteric by most junior doctors, but is a 
process in which they play an important role, and is vital for NHS funding.  
We hope that you enjoy reading this issue of The British Student Doctor. We would like 
to extend our gratitude to the medical students, junior doctors and faculty staff that 
have contributed to this issue of the journal. If any of the articles in this issue raise 
discussion, we would be pleased to consider a correspondence piece in response. Our 
author guidelines can be found on our website and offer all of the necessary guidance 
for submitting manuscripts for consideration for publication in our next issue.
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It is postulated by Mann et al. that some ethnic minorities in the United Kingdom 
(such as Asian and Black patients) experience more difficulty in being conventionally 
admitted for psychiatric conditions, and therefore present later with severe symptoms 
necessitating compulsory admission. (1) This systematic review evaluates whether 
compulsory admission rates differ between ethnicities in the UK and whether patients 
are accessing psychiatric healthcare through conventional systems (i.e. referral from 
primary care).
In our meta-analysis of 10 studies, ethnic minorities were more likely to be 
compulsorily admitted. Non-white patients were 2.38 times (95% CI: 1.55 – 3.65) 
more likely to be compulsorily admitted than White patients. Black patients were 
2.77 times (95% CI: 1.84 – 4.18) more likely to be compulsorily admitted than 
White patients. Interestingly, there was no significant difference in compulsory 
admittance rate between Asian patients and White patients, with Asian patients being 
0.96 times (95% CI: 0.78 – 1.17) more likely to be compulsorily admitted than 
White patients. Although admission rates differed between races, there was no clear 
consensus on an increased prevalence of psychiatric disorders amongst minorities 
based on 32 studies in the United Kingdom.  
The systematic review discusses possible causes for the greater likelihood for 
compulsory admissions in Black patients compared to White patients, as well as the 
non-significant result in Asian patients compared to White patients. The possible 
causes encompass social stigma associated with psychiatric disorders, and cultural and 
language barriers to conventional psychiatric healthcare in ethnic minorities.
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4Introduction
Compulsory admission is the authorised admission of a patient 
in the UK to hospital after a formal mental health assessment 
under the UK's Mental Health Act 1983, (2) which encompasses 
any psychiatric disorder except for learning disabilities. Criteria for 
detainment, for either assessment or treatment purposes, include: 
if the patient is at risk of harming themselves or the public; if the 
nature and severity of the psychiatric disorder necessitate the 
detainment; or to ensure that the patient receives the appropriate 
treatment if they lack capacity to consent. (3) 
Black patients in the UK have been shown to have higher rates 
of compulsory admission compared to White patients. (1) The 
higher detention rates have been suggested as a manifestation of 
racial discrimination and institutional racism within a healthcare 
system. (4) Lewis G et al. conducted a study where 220 British 
psychiatrists were given a questionnaire regarding a case vignette 
of a patient, whose sex and race were changed when given to each 
psychiatrist. (5) This study showed that psychiatrists, of which 79% 
were educated in the UK, view Black male patients as more violent 
compared to their White counterparts, implying the presence of 
an inherent prejudice towards Black patients. Other factors leading 
to higher compulsory admission rates amongst BME (Black and 
Minority Ethnic) groups include the lack of access for help through 
a conventional route, as one study found that African-Caribbean 
families were more likely to access help through the criminal 
system instead of through the medical system. (6) Furthermore, 
according to the 2011 National Census for English Proficiency, 
7.3% of minorities consisting of non-Whites could not speak 
English or could not speak English well, compared to only 0.7% 
in the White population, (7) this could potentially lead to language 
barriers should they require mental health services. (8) All of 
the above factors collectively contribute to patients presenting 
later with more severe symptoms and necessitating compulsory 
admission. 
The primary aim of this systematic review was to investigate 
the relationship between compulsory admission and ethnicity, 
amongst the minority groups of Blacks and Asians, regardless of 
clinical presentation. There was a secondary focus on the ethnic 
disposition to certain psychiatric illnesses, and hence the prevalence 
of psychiatric illnesses within each ethnic group. From the results 
obtained, we discuss the underlying social determinants within 
the field of mental health, and the need for improvement to deliver 
equal treatment regardless of ethnicity in the UK. In addition 
to the literature review, the study also aimed to conduct a meta-
analysis using data from the studies that meet our inclusion criteria. 
Method 
Literature search 
Search strategies for the systematic review focused on this primary 
question: is there variation between ethnic groups in terms of compulsory 
hospital admission rate? The data for meta-analysis was also generated 
from this question. There was a secondary question: is there an 
increased prevalence of psychiatric disorders amongst ethnic minorities?
The search was confined to studies published between 1983 to 
2016, due to the establishment of the Mental Health Act in 1983. 
The primary bibliographic database was PubMed and Medical 
Subject Headings (MeSH) terms were grouped as search terms, 
which included: (a) GREAT BRITAIN, HOSPITALISATION, 
ETHNIC GROUPS; (b) MENTAL HEALTH, ETHNIC 
GROUPS, GREAT BRITAIN; (c) COMMITMENT OF 
MENTALLY ILL, GREAT BRITAIN, ETHNIC GROUPS; (d) 
GREAT BRITAIN, HOSPITALISATION, ETHNIC GROUPS, 
PSYCHIATRY; (e) GREAT BRITAIN, INDIGENOUS 
GROUPS, HOSPITALISATION; (f) COMMITMENT OF 
MENTALLY ILL, (ETHNICITY or ETHNIC GROUPS or 
MINORITIES), (GREAT BRITAIN or UNITED KINGDOM). 
[Figure 1]
Our inclusion criteria for the systematic review were studies looking 
at: (i) psychiatric compulsory admission (ii) comparison between 
ethnicities including Whites v non-Whites, Whites v Blacks, 
or Whites v Asians, and (iii) studies looking at the prevalence of 
psychiatric disorders within different ethnic groups.
Our exclusion criteria were: (i) topics unrelated to psychiatric 
compulsory admissions to hospitals, (ii) lack of access to full article, 
(iii) non-primary data, (iv) studies based outside the UK and (v) lack 
of comparison to a control White group. The PRISMA diagram 
(Figure 1) demonstrates the papers included. In addition to these 
criteria, only papers which had quantitative data involving odds 
ratios between comparison groups were included in the meta-
analysis. 
Quality ratings
The quality of published studies was assessed using the criteria from 
Bhui et al. that evaluated ethnic variation in pathways to specialist 
care (Table 1). (9) The criteria focused on three domains: sample 
source and size, adjustment for confounding variables and quality of 
method of ethnic group classification.
Studies were rated on the size of the sample (0-3), adjustment for 
confounding factors (0-5) and appropriate classification of ethnic 
groups (0-3). Studies were then categorised into high-rated (8-11), 
medium rated (4-7) and low rated (0-3). Each published study 
was independently evaluated by two reviewers in order to improve 
the reliability of inclusion and data-extraction. Where differences 
existed, consensus was achieved by means of discussion. (Table 1)
Data analysis
Meta-analysis and figures were generated using Review Manager 
(v5.3, The Cochrane Collaboration, London) to pool odds-ratio for 
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5compulsory admission. Studies included in the meta-analysis did 
not adjust odds ratio for confounding factors, with analysis being 
based on uncorrected data. 
Random-effects model was used when heterogeneity (I2) was 
found to be greater than 0.5. Fixed-effects model was used when 
heterogeneity (I2) was less than 0.5.
Ethical approval
Ethical approval was not necessary as there was no intervention 
conducted for this study. 
Results 
Identifying and rating primary studies
Preliminary search terms returned 294 potentially relevant titles, 
of which 215 were unique articles. After evaluating abstracts and 
data, we found that 32 studies met the inclusion and exclusion 
criteria. These papers were subsequently rated (summarised in 
Table 2).
Compulsory admissions
From the selected 15 studies that involved comparisons of 
compulsory admission rates with ethnicity (5 high-rated, (6,10–
13), 9 medium-rated (9,14–20) and 1 low-rated (21)), all studies 
found that Black patients are more likely to be compulsorily 
admitted. From these 15 studies, 7 studies included odds ratios, 
and were thus included in our meta-analysis. Black patients are 
2.77 times (95% CI: 1.84 - 4.18) more likely to be compulsorily 
admitted than White patients (Figure 3).
Our meta-analysis of 2 studies that compared compulsory 
admissions of non-White patients compared to White patients 
suggested non-White patients are 2.38 times (95% CI: 1.55 - 3.65) as 
likely as White patients to be compulsorily admitted (Figure 2). 
Most studies suggest Asian patients are less likely to be admitted 
compared to White patients (2 high-rated (10,11), 2 moderately-
rated (14,18)), while 1 moderately-rated study (22) found that 
Asian patients are more likely to be compulsorily admitted. From 
these 5 studies, 3 studies included odds ratios, and were thus 
included in our meta-analysis. Our meta-analysis (Figure 4) of 
odds ratio in compulsory admission of Asian patients against White 
patients was inconclusive (95% CI: 0.78 - 1.17) and therefore no 
significant difference was observed.
One primary study (23) found that ethnic minorities (Asian and 
Black patients) experience difficulties going through conventional 
admission pathways for psychiatric conditions. The study proposed 
that it could potentially deter patients from seeking help earlier, 
thereby resulting in untreated psychiatric disorders.
Prevalence of psychiatric disorders
When comparing regular GP admissions and prescription 
data, studies varied on whether psychotic conditions are more 
or less prevalent amongst minority groups in the UK. 3 high-
rated (6,24,25) and 1 medium-rated study (22) concluded that 
psychotic-based admissions or prescription rates in minorities 
were not different to the White population. Contrastingly, 4 
low-rated (19,26–28) and 2 medium-rated studies (14,29) found 
that psychotic conditions were more frequent among the Black 
population. Therefore, it appears that the prevalence of psychotic 
disorders is inconclusive.
Similarly, there was no consensus on whether the prevalence of 
psychotic conditions in the Asian minority is different to the White 
population. Among the medium-rated studies, 1 found decreased 
prevalence of psychotic conditions within the Asian population, 
(30) 1 found that prevalence differences amongst Asians and 
Whites were non-significant (22) and 3 found prevalence to be 
higher amongst Asians. (14,29,31) (Table 2)
Discussion
The inequality in compulsory admissions rates in different 
ethnicities could be attributed to a variety of reasons. Firstly, 
stigma within certain ethnic groups against psychiatric disorders 
can lead to individuals avoiding treatment and refraining from 
discussing their symptoms. Secondly, greater compulsory 
admission rates could also reflect a greater prevalence of severe 
psychiatric disorders in particular ethnic groups. Thirdly, minorities 
also encounter barriers due to cultural and language differences 
which impede obtaining a diagnosis or treatment plan from their 
clinician. 
Stigma
Social stigma within ethnic groups against psychiatric disorders 
may affect the number of compulsory admissions observed. 
Anglin et al. (42) suggested that this may be the case for Black 
patients, who have a higher odds-ratio than other ethnic groups 
for compulsory admissions. This can be attributed to the lack of 
understanding of psychiatric disorders, and cultural beliefs within 
their group, that those with psychiatric disorders can cause harm to 
themselves or inflict harm on those around them through violence. 
(42) Such perceptions within the Black group can lead to people 
with psychiatric problems refraining from voluntarily seeking help, 
in order to avoid labelling, prejudice and segregation. (43,44) 
In addition, reduced help-seeking behaviour may exacerbate an 
individual’s psychiatric disorders and increase the likelihood of an 
event triggering compulsory admission. (5) Valmaggia et al. found 
that a longer duration of untreated psychosis (DUP), defined to 
be the time between the onset of the first psychotic symptom and 
the initiation of treatment, may have an association with worse 
prognosis and may also decrease the likelihood of remission from 
psychosis. (45) Furthermore, engagement of health services for 
psychosis in the prodromal phase may result in improved short-
Ethnic differences in compulsory admissions for psychiatric disorders in the UK: a 
systematic review and meta-analysis 
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misdiagnosis of conditions and contribute to the lower number 
of psychiatric admissions. (56) Therefore, the lack of detection 
of psychiatric disorders and the failure to meet the compulsory 
admission criteria for Asian groups may have led to no observable 
difference in compulsory admission rates between Asians and 
Whites.
Furthermore, a limitation of our study is that Asian patients are 
often under-represented in mental disorder prevalence studies, as 
the sample sizes are relatively small compared to other ethnicities. 
(30,34) In addition, many studies have not categorised Asians into 
subgroups despite significant cultural differences within the racial 
group. (10,11,14,18,27,33) Therefore, no conclusions can be drawn 
from a generalised grouping of all Asian patients, providing a 
possible direction for future investigations. (30)
Ethnic stereotypes and compulsory admissions
In the past, young Black men and adolescents in the UK have often 
been associated with violent crimes (57) and being ‘troublemakers’ 
(58) by the media. Singh et al. (13) suggested that such stereotyping 
of the Black population has an effect on emergency decision-
making in psychiatric wards, perhaps leading to more patients being 
compulsorily admitted. (5) It is not certain whether Black patients 
are themselves more violent in nature, with conflicting data on the 
matter, (41,59) whilst others suggest that it is the stereotyping of 
Black adolescents affecting the judgement of psychiatrists, resulting 
in greater risk of detainment. (5)
Boundaries leading to unmet needs
Under-utilisation of mental health support services at an earlier 
stage may cause patients to present with a more severe form of 
their condition which necessitates compulsory admissions. Mclean 
et al. suggest that the under-utilisation in the Black group could 
be attributed to the expectation of discrimination in the form of 
misdiagnosis, mistreatment and over-prescription which could 
deter them from using these services. (60)  Therefore, as mentioned 
previously, institutionalised prejudice may not only lead to 
misdiagnosis, but the perception of such discrimination may also 
act as a barrier preventing early access to mental health services, 
aggravating their existing mental conditions. 
Additionally, ethnic minorities may have subtly different 
presentations of psychiatric health conditions due to cultural 
variation, which can be missed by culturally unaware clinicians. 
(61) For example, psychiatrists in Chinese settings found some 
patients to report somatic symptoms in the place of dysphoria 
when presenting with depression. (62) Furthermore, Fabrega et al. 
suggest that criteria for psychiatric conditions such as the DSM-
IV (Diagnostic and Statistical Manual of Mental Disorders) have 
a Western bias and assume that psychiatric conditions present 
universally. (63)
term prognosis, decreasing the likelihood of an event which would 
require compulsory admission. (46)
Similarly, in Asian cultures, individuals with psychiatric health 
disorders are perceived to be dangerous; (47) however, the rate 
of compulsory admissions was found to be similar to the White 
population. This suggests that stigma may not necessarily have 
a consistent effect of increasing compulsory admission rates in 
different ethnic groups, suggesting the involvement of other 
sociological factors, which will be addressed below. 
Ethnic disposition to compulsory admissions-related 
conditions
Inherent differences in prevalence between ethnicities could 
contribute to the varying rates of compulsory admissions observed 
between ethnicities. In this study, compulsory admission rates 
were not normalised to prevalence rates of psychiatric conditions, 
as it was inconclusive from our systematic review whether non-
White individuals were more predisposed to psychiatric disorders 
compared to White individuals. We suggest further validation of 
our findings by adjusting compulsory admission rates to respective 
prevalence rates of psychiatric conditions.
The aetiology of schizophrenia and the difference in its prevalence 
in Black and White populations is widely reported. Members of 
the Black group in the UK were reported in studies carried out 
in the past decades to have higher rates of schizophrenia than 
White members. (48–50) A study looking at the family history of 
affected patients has found there was a seven-fold increase in risk 
for schizophrenia in second-generation African-Caribbean siblings 
of affected individuals compared to their White counterparts. This 
result suggests non-genetic factors, such as the environment, 
and a complex epigenetic interaction between environmental 
and genetic factors selectively affecting second generation Black 
patient groups. (51) Burnett et al. found that a greater proportion 
of Black patients with psychosis live alone, are unemployed and live 
in public housing compared to White and Asian patients. (23) It is 
possible that such social factors are associated with increased risk 
of developing or aggravating psychiatric illnesses. (52–54) However, 
more definite evidence is required to determine the significance 
of the associative roles of these social factors in development of 
psychiatric disorders amongst Black patients.
No significant difference was found between compulsory admission 
rates for Asian patients compared to White patients. Despite Asians 
being a minority group, our findings could be explained by under-
utilisation of healthcare services by Asians. For example, language 
barriers and cultural differences in referral networks and traditional 
treatment methods, may lead to under-utilisation of healthcare 
services. (55) Moreover, Saint et al. reported that Asian patients 
with psychological disorders, such as depression, tend to report 
more somatic symptoms than White patients, which could lead to 
7Sentell et al. found poor English proficiency to be a significant 
contributing factor towards missed diagnoses and unmet 
healthcare needs in the US. This was particularly apparent 
during consultations and treatment, which rely heavily on verbal 
communication, leading to a significant difference in outcome 
found between English-speaking minorities, and minorities with 
limited English proficiency (LEP). (64) Furthermore, patients with 
LEP without interpreters may incompletely disclose their true 
presenting symptoms and hence limit the efficacy of diagnosis and 
subsequent treatment. (65) In the United Kingdom, this may be a 
bigger issue within the Asian population, as a government census 
from 2011 found that 2.6% of the Black population could not speak 
English or could not speak English well, whereas 10.5% of the 
Asian population could not speak English at all or well. (7)
However, the result of our meta-analysis showed fewer compulsory 
admission rates within the Asian population, suggesting that there 
is a complex interaction of language proficiency with other factors. 
A detailed re-examination of the inadequacy in the mental health 
system, culturally conscious training and the use of interpreters 
during consultation for patients with LEP could be useful to tackle 
the unmet needs among ethnic minorities. (64)
Limitations arising from Classification 
The statistical conclusions on racial disparities were influenced 
greatly by the data collection methods. This study used the racial 
categories WHITES, BLACKS (African-Caribbean), and ASIANS to 
enable a statistical comparison of different ethnic groups. However, 
inclusion and exclusion to each category vary widely in different 
studies, hence masking heterogeneity within the groups. (61) In 
addition, such categories evolve from social constructs, which 
are inconsistent and based largely on subjective classification 
constructed on geopolitical divides. 
Self-identification and its influence on data 
All studies in this meta-analysis rely on self-identification of 
ethnicity by the individual. While this approach is a conventional 
and safe approach in social demographic analyses, the overall 
identification of ethnicity in genetic analyses stems from an 
individual’s ancestry informative markers, which are based on 
genomic data. Mersha et al. show that self-reporting African 
Americans can have drastically varying African and European 
ancestries. Since a similar deviation may be prevalent in the UK, 
associations between data and genetic disposition are limited. (66)
Scope of Study Selection
The studies used in this analysis were obtained from PubMed©, 
which includes the MEDLINE© database. 4 studies were included 
in the meta-analysis between Whites and non-Whites (Figure 2). 
2 studies were included in the meta-analysis between Asians and 
Whites (Figure 4). This can contribute to the distortion of data. 
Therefore, additional search terms and databases should be utilised 
to obtain further relevant studies.
Follow-up studies could analyse additional databases such 
as EMBASE (medical and pharmacologic database by Elsevier 
publishing), CINAHL (cumulative index to nursing and allied health 
literature), CANCERLIT (cancer literature research database), and the 
Cochrane Collaborative, allowing for a wider net of studies to add to 
the present body of evidence.
Conclusion
This meta-analysis determined that the likelihood of compulsory 
admission is greater in Black compared to White populations and 
inconclusive in White compared to Asian populations in the UK. 
This systematic review suggested that Asian and Black patients 
have difficulties accessing conventional admission pathways for 
psychiatric conditions due to poor cultural awareness and the 
existence of social stigma within these ethnic groups. Stigma 
towards psychiatric disorders may also reduce help-seeking 
behaviour and lead to under-utilisation of mental health facilities. 
Possible reasons preventing ethnic minorities from receiving 
adequate treatment include language barriers in consultations, 
cultural variations in the presentation of psychiatric conditions, 
and institutionalised discrimination leading to mistreatment and 
misdiagnosis. 
This study shows a clear presence of ethnic differences in unmet 
needs and a complex interplay of factors affecting compulsory 
admission rates for psychiatric disorders. Based on our findings, 
we suggest improving consultations through culturally conscious 
training for clinicians with interpreters for patients with LEP, as 
well as increasing awareness of psychiatric disorders within the 
ethnic groups. It was unclear whether the difference in compulsory 
admission rates between ethnic minorities and the White 
population was due to discrimination against ethnic minorities and 
psychiatric conditions.
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Figures
Figure 1 The Flow diagram of our systematic review
Table 1 presents the rating system used. Papers are categorized into  high-rated (8-11), moderate-rated (4-7) and low-rated (0-3)
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Author Title Rating
(Chang, Steeg, & 
Kapur, 2015)  (30) Self-harm amongst people of Chinese origin vs White people living in England: a cohort study Moderate
(Singh, Burns, Tyrer, & 
Islam, 2014)  (10) Ethnicity as a predictor of detention under the Mental Health Act High
(Corrigall & Bhugra, 
2013)  (14) The role of ethnicity and diagnosis in rates of  
adolescent psychiatric admission and compulsory detention: a longitudinal case-note study.
Moderate
(Lawlor, Johnson, & 
Cole, 2012)  (32) Ethnic variations in pathways to acute care and compulsory detention for women experiencing a mental 
health crisis
Moderate
(Connolly, Taylor, & 
Sparshatt, 2011)  (24) Antipsychotic prescribing in Black and White  
hospitalised patients.
High
(Borschmann, Gillard, 
& Turner, 2010)  (15) Demographic and referral patterns of people detained under Section 136 of the Mental Health Act (1983) 
in a south London Mental Health Trust from 2005 to 2008.
Moderate
(Bennewith, Amos, 
Lewis, & Katsakou, 
2010)  (11) Ethnicity and coercion among involuntarily detained psychiatric in-patients. High
(Tulloch, Fearon, & 
David, 2008)  (33) The determinants and outcomes of long-stay 
 psychiatric admissions: a case-control study.
Low
(Ali, Dearman, & 
McWilliam, 2007)  (34) Are Asians at greater risk of compulsory psychiatric admission than Caucasians in the acute general adult 
setting?
Moderate
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(Morgan, Mallett, 
Hutchinson, & 
Bagalkote, 2005)  (12) Pathways to care and ethnicity. 2: Source of referral and help-seeking. High
(Morgan, Mallett, 
Hutchinson, & 
Bagalkote, 2005a)  (6) Pathways to care and ethnicity. 1: Sample characteristics and compulsory admission. High
(Chowdhury, Whittle, & 
McCarthy, 2005)  (26) Ethnicity and its relevance in a seven-year admission cohort to an English national adolescent medium 
secure health service unit.
Low
(Tolmac & Hodes, 
2004)  (27) Ethnic variation among adolescent  
psychiatric in-patients with psychotic disorders.
Low
(Gudjonsson, Rabe-
Hesketh, & Szmukler, 
2004)  (35)
Management of psychiatric in-patient violence:  
patient ethnicity and use of medication, restraint and seclusion Moderate
(Webber & Huxley, 
2004)  (36) Social exclusion and risk of emergency compulsory admission, A case-control study High
(Riordan, Donaldson, 
& Humphreys, 2004)  
(37)
The imposition of restricted hospital  
orders: potential effects of ethnic origin. Low
(Oluwatayo & Gater, 
2004)  (38) The role of engagement with services in compulsory 
 admission of African/Caribbean patients
Moderate
(Commander, Odell, & 
Surtees, 2003)  (39) Characteristics of patients and patterns of  
psychiatric service use in ethnic minorities
Moderate
(Audini  & Lelliott , 
2002)  (40) Age, gender and ethnicity of those detained under Part II of the Mental Health Act 1983 Moderate
15
(Simmons & Hoar, 
2001)  (17) Section 136 use in the London borough of Haringey Moderate
(Coid, Kahtan, Gault, 
& Jarman, 2000)  (18) Ethnic differences in admissions to secure forensic psychiatry services Moderate
(Burnett, Mallett, & 
Bhugra, 1999)  (23) The first contact of patients with schizophrenia  
with psychiatric services: social factors and pathways to care in a multi-ethnic population
Moderate
(Suhail & Cochrane, 
1998)  (28) Seasonal variations in hospital admissions  
for affective disorders by gender and ethnicity.
Low
(Singh, Croudace, 
Beck, & Harrison, 
1997)  (13) Perceived ethnicity and the risk of compulsory admission. High
(Koffman J, 1997)  (19)
Ethnicity and use of acute psychiatric beds: one-day survey in north and south Thames regions. Low
(Davies, Thornicroft, 
Leese, & 
Higgingbotham, 1996)  
(21)
Ethnic differences in risk of compulsory psychiatric admission among representative cases of psychosis in 
London
Low
(Callan, 1996)  (25)
Schizophrenia in Afro-Caribbean immigrants High
(Thomas, Stone, 
Osborn, & Thomas, 
1993)  (29)
Psychiatric morbidity and compulsory admission among UK-born Europeans, Afro-Caribbeans and Asians 
in central Manchester. Moderate
(Glover, 1991)  (31)
The use of inpatient psychiatric care by immigrants in a London Borough Moderate
(Dunn & Fahy, 1990)  
(41) Police admissions to a psychiatric hospital. Demographic and clinical differences between ethnic groups. Moderate
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(McGovern & Cope, 
1991)  (20) Second generation Afro-Caribbeans and young whites with a first admission diagnosis of schizophrenia Moderate
(Ineichen, Harrison, & 
Morgan, 1984)  (22)
Psychiatric hospital admissions in Bristol. I. Geographical and ethnic factors. Moderate
Table 2 shows the papers we included in our systematic review
 
Figure 2: Whites v non-Whites. Heterogeneity = 0%. Pooled results suggest non-White patients are 2.38 (1.55-3.65) times more likely to 
be compulsorily admitted compare to White patients.
Figure 3: Whites v Blacks. Heterogeneity = 84%. Pooled results suggest Black patients are 2.77 (1.84-4.18) times more likely to be 
compulsorily admitted compare to White patients.
Figure 4: Whites v Asians. Heterogeneity = 0%. Pooled results suggest Asian patients are 0.96 (0.78-1.17) times more likely to be 
compulsorily admitted compare to White patients.
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Summary
Congenital talipes equinovarus (CTEV) is the most common 
musculoskeletal condition in newborns, affecting one-to-two per 
thousand babies. The Ponseti method is a treatment regime for 
the management of CTEV which describes a detailed method of 
manipulation, casting and bracing. Despite its initial publication in 
1963, it only started to become popular in the 1990s, coming to UK 
shores in 1997 when NHS Physiotherapist Steve Wildon widely 
popularized the method around the country, including in Morecambe 
Bay. Patients who are treated with the Ponseti method report high 
levels of satisfaction many years after treatment. The body of literature 
evaluating the steps of the Ponseti method has grown in the last decade 
as the technique has become the gold standard treatment for clubfoot. 
Future research will look at how the Ponseti method can be improved in 
the management of CTEV. 
Relevance
Medical students should be aware of CTEV and understand the steps in 
management of this common musculoskeletal condition in newborns.
Take Home Messages
• CTEV is the most common musculoskeletal condition in newborns 
and the current gold standard management is the Ponseti method.
• Ponseti method enables us to correct the majority of clubfeet with its 
conservative approach.
• Relapses which occur have a good prognosis when treated with 
surgery in the form of a tibialis anterior tendon transfer. 
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Introduction
Treatment of Congenital Talipes Equinovarus (CTEV), also known as 
clubfoot, has changed dramatically over the last twenty years with 
the introduction of the Ponseti method. This conservative mode of 
treatment, which involves manipulating joints using casts, was first 
described by Dr. Ponseti in 1963 (1) at the University of Iowa and 
is considered to be the most effective method of treating clubfoot 
worldwide. Ponseti published a further detailed description of his 
method in 1972 (2) and reported the results of his method in a 
series of long term studies. (3-5) The recommendations which he 
made in his first two papers are still valid today with only minor 
adjustments being made by himself or his colleagues. 
Prior to the introduction of the Ponseti method, a number of 
conservative techniques were used to treat clubfoot. (6) The first 
documented treatment for clubfoot by Hippocrates was similar to 
the Ponseti method used today.  As early as 400 BC, Hippocrates 
described managing clubfoot with manipulations and bandages 
as if the foot was a ‘wax model’ which needed to be manipulated 
gently. Treatment options then varied between surgical and 
conservative management, with popular methods including the 
Kite method, French method and surgery. (6) 
The Ponseti method initially had a slow uptake and has only been 
accepted widely within the past 15 years, despite its original 
description 52 years ago. The method now, however, is firmly the 
choice of management. The Ponseti method was found to be the 
treatment of choice among members of the Paediatric Orthopaedic 
Society of North America (POSNA), with 96.7% stating that it was 
their preferred method for the treatment of idiopathic clubfoot. 
(7) A series of reviews from around Europe and beyond have also 
yielded results showing the superiority of the Ponseti method. 
(8-10) When compared directly to surgical treatment, the Ponseti 
method has reduced stiffness and increased range of motion of the 
ankle joint, in addition to not being exposed to the risks of surgery. 
(11) 
Congenital Talipes Equinovarus (CTEV/Clubfoot)
Clubfoot (CTEV) is the most common musculoskeletal condition 
in newborns, affecting one-to-two per thousand babies. (12) In 
most cases, the aetiology is unclear, and as such termed idiopathic 
CTEV. In other cases, it may be associated with a genetic syndrome 
such as spina bifida. (13) There are a number of hypotheses for 
the cause of CTEV, such as neuromuscular disease, (14) lack of 
foetal movement in utero (15) and genetic microduplication. (16) 
Boys are more affected than girls (2.5:1) (17) and the condition 
has a 50% chance of being bilateral. (18) It characteristically has 
four deformities, with forefoot cavus and adductus and hindfoot 
varus and equinus. (6) This leaves the foot looking like it has been 
internally rotated with the toes almost facing upwards towards the 
midline of the body.
From an anatomical point of view, the appearance is due to the 
talus being distorted and focussed laterally and the navicular 
being subluxated off the talar head so that it may articulate with 
the medial malleolus. The ankle and subtalar joints are in a fixed 
equinus, the calcaneus is in equinus, varus and rotated internally 
(Figure 1). These changes in the shape and position of the tarsal 
bones appear to have an excessive pull on the tibialis posterior, 
gastrocnemius, soleus, tibialis anterior and long toe flexors. The size 
of the leg muscles is negatively correlated with the severity of the 
clubfoot and the ligaments in the affected clubfeet are very thick 
and taut. 
Casting and Manipulation
The Ponseti method to correct clubfoot is started within the first 
couple of weeks from birth.  The method involves five-to-eight 
weeks of leg plaster casts, which run from the toe to the groin, 
which are changed once a week. Short leg casts are not used as 
they cannot hold the abduction and have the potential to slip 
off, recognised to be an important factor in the development 
of complex clubfoot (feet which significantly shortened with a 
rigid equinus and severe plantar flexion of all metastarsals). (19) 
During this time a number of stretches are used to help correct the 
deformity, which is recommended to be performed prior to casting 
(Figure 2). Firstly, the cavus is corrected with forefoot supination 
with pressure applied to the first metatarsophalangeal joint in 
order to raise it, meaning that the forefoot must be supinated to 
align it with the hindfoot in order to decrease cavus.  The varus 
is then corrected by rotating the calcaneus and forefoot around 
the talus, with the head of the talus acting as a fulcrum, so that 
the foot is pointing now pointing outwards. It is important not to 
touch the calcaneus as it may block the motion of calcaneus which 
must be able to move from underneath talus. Finally, the equinus is 
corrected with stretches to dorsiflex the foot. It is important not to 
actively dorsiflex the foot prior to subtalar joint correction. 
One of the most common errors which occurs during casting 
and stretching is the inadequate counter pressure on the talus. 
(20) Talus is very small in infants and is often more superior and 
anterior than would be expected. If counter pressure is applied too 
inferiorly or the pressure is over too broad of an area, calcaneus 
can be blocked and cannot move out from underneath the talus. 
When this happens, the abducting forces act on Lisfranc joint (the 
articulation between the midfoot and the forefoot) and the Chopart 
joint (transverse tarsal joint) causing abduction of the midfoot and 
possibly the formation of a lateral crease. This is regarded as a red 
flag during casting. (21) 
In terms of the types of cast, Ponseti recommended a thin cast with 
little padding which should be moulded to the foot. The risk of the 
cast slipping can be prevented by using a cast with a well moulded 
heel and one which is high enough to reach the groin with the knee 
in at least 90® degrees of flexion. The second and third casts carry 
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the highest risk of slipping off, particularly if patients have a severe 
equinus and cavus. (21) Casts should only be removed just before 
the new cast is applied. Premature removal of casts the night before 
a new one is applied has been shown to result in a higher number 
of casts being required for correction. (22) The casts are usually 
changed once a week but accelerated protocols have also been 
reported; Morcudende et al. (5) found similar success rates when 
changing the casts every five days and Harnett et al. (23) found 
similar results when changing casts three times per week compared 
to a weekly change group. Shorter intervals between cast changes, 
however, may not be preferable. Pirani et al. suggested that tissues 
may need a certain amount of time in the corrected position within 
the cast in order to adapt. (24) This is due to changes in growth as a 
result of different mechanical loading in fast-growing tissues. (24)
CTEV severity and treatment progress using the Ponseti method 
is measured using the Pirani score. (25) The score shows whether 
the deformity is correcting normally or whether there is a problem. 
Scoring involves looking at six signs, three in the midfoot (such as 
the lateral head of the talus) and three in the hindfoot, (such as the 
posterior crease) and a score of 0, 0.5 or 1 is given depending on 
severity of the deformity. (25) A score of four or more means that 
the patient is likely to require at least four casts, whereas a purely 
hindfoot score of 2.5 has a high chance of requiring a tenotomy. 
(25) 
Percutaneous Achilles tenotomy
Following casting, many patients will require a Percutaneous 
Achilles tenotomy (pAT) to relieve the remaining equinus. A pAT 
involves releasing the Achilles tendon from its insertion on the 
calcaneum.  Ponseti originally reported that pAT was required in 
79% of cases, (1) with subsequent studies reporting rates similar 
to this (80-90%). (5, 26) Timing of the procedure is crucial to the 
success of the procedure. Ponseti recommended pAT when there 
was less than 15-20 degrees of dorsiflexion and when the foot 
had been abducted to at least 60 degrees. (20) This is necessary 
as to allow the calcaneus to be able to move out completely from 
underneath talus, correcting the subtalar misalignment.  If pAT 
is attempted before 60-70 degrees of abduction and before the 
correction of the subtalar alignment the hindfoot will likely stay 
uncorrected.  After the operation, a post tenotomy cast should 
be applied and moulded in maximum abduction and dorsiflexion 
to achieve good correction. If the foot is not dorsiflexed after the 
tenotomy, this may result in insufficient dorsiflexion once the cast 
has been removed.
The tenotomy was originally recommended to be performed under 
local anaesthetic by Ponseti, however, a number of studies have 
used either local or general anaesthetic with both being found to 
be safe and effective. (27, 28) A recent review article concluded 
that pAT can be potentially performed under either local or general 
anaesthesia with the choice being mostly dependent on the setting 
and experience of the staff involved. (21)
Boots and braces
Following the casting and manipulation phases of treatment, the 
affected feet are fitted with open-toed boots attached to, and 
connected to one another, via a “Denis Browne bar”. The bar-
connected brace maintains the corrected foot in 60 to 70 degrees 
of external rotation on the affected side and in 30 to 40 degrees of 
external rotation on the normal side. The bar should be bent from 5 
to 10 degrees and hold the feet in a valgus position with sufficient 
length so that the heels of the shoes are the same as the width of 
the shoulders. (29) Whilst wearing the brace, the shoes maintain 
the foot in 10 to 15 degrees of dorsiflexion. (30) Although the foot 
appears to be ‘over-corrected’ into abduction whilst in the brace, 
the result is not a real overcorrection but full abduction. (30) 
Initially, Ponseti had described the use of such a foot abduction 
orthosis (FAO) following three months of a full time brace for an 
additional twenty-one months (average mean duration). (1) Ponseti 
found that this yielded a high recurrence rate and recommended 
that the FAO to be used at night for a number of years in his 
second paper. (2) These shoes are required to be worn for twenty-
three hours a day for the following three months and then during 
the night for approximately four years. Following successful 
management with the Ponseti method, the patient has a pain-free, 
functional foot with good mobility. They are able to wear non-
modified shoes. 
One of the most significant risk factors for relapse of clubfoot 
after correction is non-compliance with the boots, with parental 
educational level being an important factor. (31) Studies have 
looked into ways of improving compliance, with the use of a 
dynamic brace (32) and using strategies to educate the parents and 
provide written instructions (33) both resulting in a higher level of 
compliance.  
Results of treatment
The Ponseti method has been found to yield very good results 
for correcting clubfoot with an initial success rate of 90% (1) and 
98% reported. (5) 90% of a group of patients Ponseti treated with 
his method were also found to be satisfied with the function and 
appearance of their feet when followed up nineteen years later. 
(3) Some of these patients were followed up a further eleven years 
later showed no deterioration of the appearance or function of 
their feet. (4)
Despite the high success rate using the Ponseti method, 
complications may arise. Overcorrection has been reported as a 
common complication with one study reporting 12.2% of feet 
being left with a valgus overcorrection. Overcorrection was also 
found to be a significant predictor of pain complaints following 
Ponseti therapy (p=<0.001). (34)
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For patients who relapse, a tibialis anterior tendon transfer is 
recommended. This procedure was found to be performed in 21% 
of feet treated by Ponseti in a follow-up study. (35) A similar figure 
has been found in other studies. (36, 37) The procedure is especially 
recommended if the relapse is mostly dynamic supination and 
adduction. In this procedure it is recommended that a full transfer 
to the third cuneiform is performed. (1, 2) Relapse may occur after 
this procedure though; a recent study reviewed patients treated 
by tibialis anterior tendon transfer after initially having successful 
treatment from the Ponseti method. They found that relapse after 
tibialis anterior tendon transfer occurred in 15% of feet. (38)
Finding its feet in the UK
With over fifty years of use in the United States, the Ponseti method 
was popularised on British shores in 1997 in the North West with 
NHS Physiotherapist Steve Wildon. Mr Wildon approached Mr 
Paul Marshall, the current lead clinician for the Department of 
Orthopaedics and Trauma at the Royal Lancaster Infirmary, to start 
this form of treatment in the UK. The method has only grown in 
its use since then with a centre set up in Manchester dedicated to 
the treatment of clubfoot with the Ponseti method by Miss Naomi 
Davis, a Consultant Paediatric Orthopaedic Surgeon in Manchester. 
Miss Davis is a former registrar of Mr Paul Marshall. Miss Davis set up 
the Ponseti Clinic for Clubfoot Management in Manchester in early 
2002.
There are, however, a number of variations in how the Ponseti 
method is used depending on the part of the country. 
Comparing the University Hospitals of Morecambe Bay Trust 
method of implementing the Ponseti method to the method 
at the Manchester clinic yields a couple of differences. Firstly, in 
Manchester, the stretches which are used during the casting phase 
are not performed. Secondly, in Manchester a Plaster of Paris is used 
compared to a soft cast which is used within the Morecambe Bay 
trust. Plaster of Paris is a cheaper alternative to the soft cast but it 
is harder to remove. This may be to do with the number of patients 
seen at the respective sites, as the Manchester site sees many more 
clubfeet due to the area it covers compared to the Morecambe 
Bay site, so more staff are available to remove the cast and having 
a cheaper cast makes treating these patients more economically 
viable. 
Conclusion
Despite taking a number of decades to become the mainstay of 
treatment, the Ponseti method enables us to correct the majority 
of clubfeet with its conservative approach. In addition, the 
method is popular amongst patients, with follow-up studies from 
Ponseti showing high rates of satisfaction and no deterioration of 
appearance of function of the feet. The last decade has highlighted 
the popularity of the regime, reflected by the increasing body of 
literature analysing the Ponseti method. Research is now focusing 
on making the Ponseti method more effective by aiming for a 
shorter casting time or a reduced rate of relapse, using techniques 
such as an accelerated method, (23) adjuvant therapy with 
Botulinium A toxin (39) and different casting methods. (40)
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Summary
There is a growing global trend towards the decriminalisation of 
cannabis use.  Several countries have already legalised this drug for 
medicinal and recreational use, and more are expected to continue 
this trend in the future.  Inhalation and ingestion of cannabis are 
the two basic methods of consumption, and each provides unique 
bioavailability mechanisms. Anticipating the increasing social and legal 
acceptance of cannabis, this article provides a basic understanding of 
the geographic acceptance, methods of use, bioavailability of active 
ingredients, and mechanisms of absorption in the human body.
 
Relevance
The growing acceptance of cannabis increases the probability that 
current medical students will encounter patients using cannabis 
in some form. This is a significant trend especially considering the 
psychoactive effects of the drug and the medicinal benefits. Having a 
basic knowledge of the methods of consumption and the longevity 
of cannabinoid compounds in the human body will help students 
and practicing physicians better diagnose patients and implement 
optimum wellness plans. 
Take Home Message
As societies and lawmakers increasingly accept the use of cannabis, it’s 
important that medical professionals have a basic knowledge of the 
various delivery methods and the impact of cannabinoid compounds 
in the human body. Patient care can be enhanced through a better 
understanding of how the drug is used and how it affects the human 
body. This educational piece provides a step in that direction.
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Introduction
The global decriminalisation of cannabis is increasingly hitting 
the newswires these days. With a long-recorded history of human 
use, this drug contains approximately 60 pharmacologically active 
cannabinoid compounds including tetrahydrocannabinol (THC) 
and cannabidiol (CBD), which are known for their psychoactive and 
non-psychoactive effects respectively. (1, 2) While the popularity 
of cannabis as a recreational drug is rooted in its ability to alter 
sensory perception, a growing body of research also points 
to several medical benefits, including the relief of chronic and 
neuropathic pain, and as a treatment for insomnia, anxiety, epileptic 
seizures and nausea. (3, 4, 5, 6, 7, 8) 
The Growing Acceptance of Cannabis
The attractiveness of cannabis is growing worldwide. According to 
the United Nations Office on Drugs and Crime, about 3.8 percent 
of the global population, or an estimated 183 million people, use 
cannabis making it the third most popular recreational drug in the 
world, behind alcohol and tobacco. (9) More importantly, while 
it is still an illicit substance in many parts of the world, there is a 
growing trend towards legalisation for medical and recreational 
use. (10, 11) For example, in Uruguay and Portugal, cannabis is now 
completely legal, while in countries such as the Czech Republic, 
Finland, Norway, the Netherlands, Spain and Greece, cannabis is 
legal for medicinal use or decriminalised in some form. (12, 13) 
Across the pond in North America, there are 29 U.S. states that have 
legalised medicinal cannabis and 9 of these have also legalised it for 
recreational use. (14) This global momentum towards acceptance 
will continue with the Canadian government slated to become 
the first G7 country planning to fully decriminalise marijuana in 
2018, while further U.S. legalisation is also underway in 8 additional 
states. (15-17) Although cannabis is still illegal in the United 
Kingdom, attitudes are changing with roughly half of the public 
(47%) supporting sale of the drug through licensed shops. (18)
Bioavailability and Longevity of Cannabinoid Compounds
With this growing acceptance, it is especially useful for medical 
professionals to know how the drug is consumed and the 
bioavailability of cannabinoid compounds upon entering the 
body. Firstly, we know that the drug is typically inhaled or ingested, 
and that smoking is the most common method of inhalation. 
The bioavailability of the active ingredients and how quickly the 
psychotropic effects are experienced are affected by several factors, 
including potency, ratio of THC to CBD, method of delivery, stomach 
contents, metabolism, biochemistry and interaction with other 
medications. The act of smoking cannabis provides the highest 
bioavailability and involves the decarboxylation of the naturally 
existing tetrahydrocannabinolic acid (THCA) into THC (delta-9 THC). 
These active ingredients then travel through the airway and into 
the lungs where they are absorbed into the bloodstream resulting 
in maximum plasma concentration within minutes.  One study 
found that inhalation resulted in bloodstream absorption rates of 
10 to 45 percent, with bioavailability peaking 3 to 10 minutes after 
inhalation. (19) Psychoactive effects and increased heart rate are 
experienced between 30 seconds and 2 minutes after inhalation 
once the THC compounds reach the brain – and taper off within 
2 to 3 hours. (20) In contrast, when cannabis is ingested within 
foods or drinks it is processed in the highly acidic environment 
of the stomach, which damages the cannabinoid molecules and 
reduces bioavailability. Nevertheless, remaining molecules are 
absorbed in the gastrointestinal tract and liver, which metabolise 
the THC into 11-hydroxyl-delta-9-THC, a smaller lipophilic molecule 
able to cross the blood-brain barrier. This results in a more 
prolonged psychotropic effect compared to inhalation. In two 
different studies, oral administration resulted in an absorption rate 
between 4 to 20 percent - the effects are experienced 30 minutes 
to 2 hours after ingestion and can last up to 8 hours. (21, 22)  As 
an alternative delivery method, there are also cannabis-infused 
balms, oils and lotions that are absorbed through the skin.  This 
approach activates local cannabinoid receptors and is often used 
for localized pain relief without the broader psychoactive effects. 
With all of these methods, the external cannabinoids act on the 
body’s own endocannabinoid system and stimulate cannabinoid 
CB1 and CB2 receptors, which are involved in the homeostasis of 
biological functions. For example, the anti-nausea effects of THC 
are mediated by the interactions of THC with CB1 receptors in 
the dorsal vagal complex. (23) In contrast, CBD, the second most 
common cannabinoid, exerts antiemetic properties through other 
mechanisms and different pathways in the brain resulting in few 
psychotropic effects.
Conclusion
Societies and lawmakers are increasingly accepting the use of 
cannabis, especially in light of a growing body of research pointing 
to various medical benefits. This has resulted in a global trend 
towards decriminalization, which is expected to encourage future 
use. Understanding the basic delivery methods of inhalation and 
ingestion, and the corresponding bioavailability and longevity 
of cannabis compounds is important in order to better diagnose 
patients and implement optimum wellness plans. 
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Recent advances in our 
understanding of the pathobiology 
of non-coding RNA
Summary
The central dogma of molecular biology recognised RNA as a 
mere intermediate between DNA sequence and proteins, the main 
protagonists of cellular functions. The shadow of a wrinkle in this 
concept appeared when the Human Genome Project revealed that 
protein-coding genes only account for 2% of our genome and the 
remaining 98% was originally dismissed as elusive “junk DNA.”
Relevance
Recent advances in next-generation sequencing provided tantalising 
evidence that 70-90% of human genome is actively transcribed(1). 
Numerous studies started discerning the functional importance of 
long and short (>200 and <200 nucleotides, respectively) non-coding 
transcripts far beyond the initial textbook-engraved infrastructural and 
information-transmitting role of rRNA, tRNA and mRNA. 
Take Home Messages
By “rediscovering the junk,” this essay reviews a selection of recent 
disease-associated advances in the field of small non-coding RNAs 
before extending the discussion to long non-coding RNAs and 
finally to the overarching concepts of competing endogenous RNAs 
(ceRNAs) and ‘social’ RNA. 
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RNA interference (RNAi)
RNA interference is a process whereby micro RNA (miRNA) 
and small interfering RNA (siRNA) molecules inhibit target gene 
expression by acting on mRNA. The first miRNA to be identified, 
lin-4, was discovered as a short non-coding RNA required for 
repression of lin-14 gene and subsequent maturation of C. elegans 
larvae. (2) The sequence of lin-4 displayed complementarity to 
the 3’ untranslated region (UTR) of lin-14 mRNA, (2) suggesting 
that lin-4 regulates lin-14 expression through an RNA-RNA 
interaction. The discovery of let-7 miRNA (3) and its conservation 
from worms to humans (4) first underscored the prevalence and 
functional importance of miRNA-dependent gene regulation. 
Although estimated to represent less than one percent of our 
genome, miRNAs have been proposed to regulate as many as 92% 
of human genes. (5)
What is the mechanism of gene regulation by miRNAs? The 
process of miRNA biogenesis typically starts with RNA 
polymerases transcribing miRNA genes into primary miRNAs, 
which fold to form hairpin-loop structures (Figure 1). These are 
recognised and cleaved by the Microprocessor complex to form 
precursor miRNAs (pre-miRNAs). Following nuclear export, 
pre-miRNAs are cleaved by a protein complex involving Dicer 
endonuclease and one of the resulting 21-23bp strands assembles 
with Argonaute proteins into an RNA-induced silencing complex 
(RISC). Using miRNA as a guide, RISC binds to complementary 
miRNA-response elements (MREs) in 3’ untranslated region 
(UTR) of target mRNAs leading to mRNA cleavage or 
translational inhibition. While miRNAs are endogenous, siRNAs 
are exogenous RNA duplexes that enter the cell, are cleaved 
by Dicer and follow the same processing and functional path as 
miRNAs. 
About 20 years since their discovery and landmark observations, 
miRNAs are recognised as regulators of most cellular processes, 
with their derangements reported in a host of human disease.
miRNAs in tumorigenesis
Tumorigenesis is generally associated with gain-of-function 
mutations or amplification of oncogenes and/or loss-of-function 
mutations in tumour suppressor genes (TSG). Oncomirs, 
i.e. miRNAs that promote cancer, typically repress TSGs. 
The polycistronic cluster miR-17-92 is located in a region of 
chromosome 13q and is frequently amplified in tumours. (6) The 
binding of oncprotein MYC to this cluster drives the expression 
of six miRNAs with reported roles in cell proliferation, apoptosis 
and angiogenesis. (7) Overexpression of this cluster in MYC-
driven mouse model of lymphoma accelerated tumorigenesis by 
suppressing apoptosis, (8) identifying miR-17-92 as an oncomir 
normally acting downstream of MYC. 
The first evidence for altered miRNA expression in cancer 
came from genome-wide studies in patients with B-cell chronic 
lymphocytic leukaemia (B-CLL), the most prevalent type of adult 
leukaemia. Using somatic cell hybridisation, 68% of B-CLL 
patients were found to carry a deletion in the gene cluster encoding 
miR-15 and miR-16 miRNAs. (9) Prolonged survival of B cells in 
B-CLL corresponded to increased expression of the anti-apoptotic 
protein Bcl-2 (among other targets), a process successfully reversed 
by forced expression of miR-15 and miR-16 into cultured B cells 
of B-CLL patients. (10) This demonstrated the tumour-suppressing 
function of miR-15 and miR-16, which was confirmed in mouse 
xenograft experiments: human prostatic tumour grafts transfected 
with miR-15 and mir-16 displayed increased regression compared 
to untransfected controls. (11) Hence, miRNAs can function as 
TSGs and their restoration bears therapeutic promise.
Human cancers typically show a global decrease in miRNA 
expression, (12) which could reflect the undifferentiated state of 
tumours or causally contribute to the transformed phenotype. To 
answer this question, Kumar and co-workers generated mouse and 
human lines deficient in miRNA processing proteins Drosha or 
DGCR8 (components of the microprocessor complex) and Dicer1. 
These lines displayed a substantial decrease in steady state miRNA 
levels, increased growth in soft agar cultures and more malignant 
behaviour when injected into nude mice compared to controls, (12) 
demonstrating that miRNA pathways tend to act as an overall brake 
on cancer growth rather than simply reflecting the undifferentiated 
state. Interestingly, overexpression of let-7 miRNA alone reversed 
the in vitro effects of Dicer1 knockdown (12), implying that let-7 
may be the key TSGs among miRNAs. Let-7 miRNAs target 
the KRAS oncogene, (13) whose properties have to date thwarted 
all therapeutic efforts using small molecule inhibitors. Hence, 
overexpression of let-7 miRNA provides an alternative approach to 
target KRAS, which is frequently mutated in human cancer. (14)
miRNAs in immunity
One caveat in therapeutic application of miRNAs is that a 
single miRNA typically induces pleiotropic effects in cell types 
with different transcriptional profiles. While let-7 suppresses 
tumorigenesis in cancer cells, (13) it was demonstrated to play a 
diametrically opposite role in tumour-associated macrophages 
(TAMs). (15) TAMs typically exist as two populations: tumour-
reactive (M1) macrophages attack tumour cells whereas tumour-
tolerant (M2) macrophages supress anti-tumour immunity. Global 
ablation of miRNAs by deletion of Dicer1 in mice resulted in 
polarisation of M2 towards M1 population and boosted anti-
tumour reactivity. (15) This process was rescued by forced 
expression of let-7 miRNA, (15) suggesting that the tumour-
tolerant M2 phenotype is chiefly maintained by let-7 miRNA.
In adaptive immunity, tolerance mechanisms including regulatory 
T (Treg) cells prevent other T cells from reacting against self-
proteins, thereby limiting autoimmune disease. Tregs exist in two 
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populations: natural nTregs differentiate in the thymus whereas 
induced iTregs are induced by IL-2 and TGFβ stimulation of 
naïve CD4 T cells in the periphery. nTregs and iTregs differ 
epigenetically (16) and iTregs were shown to lose Treg markers 
(and immunosuppressive function) and differentiate into exTreg 
cells (16) (Figure 2). The latter recognise self-antigens and 
can, instead of suppressing autoimmunity, actually attack self-
antigens themselves. (17) This raises the question of what causes 
iTregs to become exTregs? Immunosuppressive Treg cells and 
immunoreactive TH17 cells have diametrically opposite functions, 
yet share many differentiation factors. In the presence of IL-1β 
(from activated monocytes) and IL-2, iTregs downregulate the 
canonical Treg transcription factor Foxp3 (i.e. become exTregs) 
and start producing pro-inflammatory IL-17, thus functionally 
resembling TH17 cells. (18) Interestingly, the transition from 
iTreg cells to TH17-like exTreg cells has been shown to involve 
miRNAs. Peripheral CD4 T cells from humans with systemic 
lupus erythematosus and Crohn’s disease as well as autoimmune 
mouse models demonstrated downregulation of miR-125a, which 
stabilises both the commitment and regulatory capacity of Treg 
cells. (19) Mice deficient in miR-125a spontaneously developed 
autoimmune disease, which was successfully reversed using 
synthetic miR-125a analogues. (19) Hence, miR-125a serves as a 
transcriptional regulator of Treg cells whose forced re-expression 
can re-wire aberrant Treg cells back to normal physiological 
function and prevent autoimmunity.
tRNA fragments in transgenerational epigenetic inheritance
Besides the conventional role of tRNAs in translation, striking 
new evidence suggests an active role of tRNA fragments (tRFs) 
in transgenerational inheritance independent of changes in DNA 
sequence. Using in vitro fertilisation, offspring of males consuming 
a low-protein diet exhibited significant hepatic up-regulation 
of squalene epoxidase (involved in cholesterol biosynthesis) 
compared to controls, implying that paternal diet can affect 
offspring metabolism via information located in sperm. (20) Deep 
sequencing of small RNAs in sperm of low-protein diet versus 
control males demonstrated the former to have increased abundance 
of tRFs, whose injection into normal zygotes recapitulated the 
metabolic phenotype of tRF donors. (21) Locked nucleic acid 
(LNA) oligonucleotides blocking tRFs derived from the 5’ end 
of glycine tRNA resulted in dramatic up-regulation of about 70 
genes, (22) demonstrating that tRFs can profoundly influence the 
transcriptional profile of the zygote. Hence, sperm tRFs present a 
paternal epigenetic factor mediating transgenerational inheritance of 
diet-induced metabolic disorders.
Long non-coding RNAs
While short non-coding RNAs mainly affect mRNA stability 
and translation, the functional repertoire of long non-coding (lnc) 
RNAs is considerably more versatile. This includes chromatin 
binding and epigenetic regulation, protein scaffolding and 
“sponging” of miRNAs as discussed below.
Selective targeting of mitochondrial metabolism in melanoma 
through the lncRNA SAMMSON
The survival of several tumours requires oxidative phosphorylation, 
which stimulated the development of metabolism-targeting anti-
cancer agents. Single nucleotide polymorphism (SNP) array data 
revealed that focal amplifications of chromosome 3p characteristic 
of melanoma invariably encompass a newly annotated lncRNA 
gene SAMMSON, which was found to be selectively expressed in 
more than 90% of human primary and metastatic skin melanomas 
as demonstrated by RNA sequencing. (23) Prognosis and clinical 
success of current anti-melanoma therapies is associated with 
mutational status of BRAF, NRAS and TP53 of the tumour while 
chronic treatment with novel BRAF inhibitors, e.g. vemurafenib, 
invariably leads to drug resistance. (24) Promisingly, silencing 
SAMMSON using antisense oligonucleotides reduced proliferation 
of all melanoma cultures independently of BRAF, NRAS and p53 
status and preserved sensitivity to BRAF inhibitors. (23) RNA pull 
down and mass spectroscopy identified a SAMMSON-associated 
protein, p32, known for its role in maintenance of mitochondrial 
membrane potential and oxidative phosphorylation. (25) Antisense 
nucleic acid-induced silencing of SAMMSON decreased 
mitochondrial membrane potential and triggered apoptosis, and 
the effect was rescued by reintroduction of p32. (23) Hence, 
SAMMSON silencing inhibits the survival of melanoma at least 
partly by disrupting p32-mediated mitochondrial functions. 
How does impaired mitochondrial function hinder cell 
proliferation? Collapsed mitochondrial membrane potential impairs 
the import of cytoplasmic proteins into mitochondria, which leads 
to toxic accumulation of mitochondrial precursors in the cytosol, 
stalling of the cell cycle and/or apoptosis. (26) The relevance of 
this mechanism was confirmed by exposure of human melanoma 
cells to inhibitors of translation, which abolished the lethal effect 
of SAMMSON silencing. (23) Importantly, intravenous treatment 
with SAMMSON-silencing antisense nucleic acids significantly 
suppressed the growth of human melanoma tumours injected into 
mice, (23) identifying SAMMSON as an attractive therapeutic 
target for the disruption of mitochondrial metabolism selectively in 
melanoma.
Competing endogenous RNA (ceRNA)
Specific miRNA molecules can be repressed experimentally using 
chemically modified antisense oligonucleotides or artificial miRNA 
sponges. The latter are synthetic RNA constructs harbouring 
multiple miRNA-binding elements (MREs). The competition 
for shared miRNAs between decoy MREs of the sponge and 
functional MREs of natural miRNA target transcripts titrates 
the amount of functional miRNA within the cell. Growing 
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understanding of human transcriptome led to postulating the 
existence of natural RNA sponges, whereby all (co-localised) 
RNA transcripts that contain MREs can communicate with and 
regulate each other by competing for shared miRNAs, thus acting 
as competing endogenous RNAs (ceRNAs) (27). In this way, 
protein-coding mRNAs may possess an additional non-coding 
function as ceRNAs. Though ceRNA research is still in infancy, 
the ceRNA role of lncRNAs, (28) mRNAs (29) and circular 
RNAs (30) has already been reported. For example, the non-coding 
PTENP1 pseudogene has been reported to regulate the levels of 
its cognate gene, the tumour suppressor PTEN, by competing for 
shared miRNAs. (31) PTENP1 pseudogene is frequently lost in 
human cancers, (31) which results for uncontrolled repression of 
PTEN protein by miRNAs. Intriguingly, comparison of cultured 
human transformed versus untransformed cells revealed that the 
former express mRNAs with shorter 3’ UTR regions. (32) While 
reducing their regulation by miRNA, this property also diminishes 
their ceRNA role. The functional consequence of this, if any, still 
remains to be elucidated. 
RNA trafficking and the controversy of ‘social’ RNA
Exosomes are plasma-membrane-derived vesicles that transfer 
proteins, mRNAs, miRNAs and other ncRNAs between cells. 
Returning to the study of sperm tRNA fragments (tRFs) in 
transgenerational inheritance: deep sequencing of sperm cells at 
different locations along the epididymis demonstrated that all sperm 
cells contained comparable amounts of tRNAs, yet the abundance 
of tRFs increased distally along the epididymis. (22) This suggests 
that tRFs are not the product of tRNA degradation within the 
sperm. Instead, deep sequencing showed the sperm tRFs to be 
derived from exosome-like vesicles released by epididymis termed 
epididymosomes, (22) suggesting that functional ncRNAs can 
participate in intracellular communication. 
miRNAs are trafficked around the body in high-density lipoprotein 
(HDL) particles. (33) The HDL-miRNA profile of healthy human 
subjects was found to be significantly different from patients with 
familial hypercholesterolemia and the two types of HDL induced 
different transcriptional profiles in cultured human hepatocytes as 
demonstrated by miRNA microarrays. (33) This demonstrated that 
HDL-transported miRNAs are functional, differ in disease states 
and can alter the transcriptome of target tissues.
Lastly and most controversially, the ‘social’ RNA hypothesis 
posits that the RNA world extends beyond the boundaries of an 
organism. (34) Within numerous limitations, RNA-containing 
complexes in the environment could influence gene expression 
profiles between animals of the same species as well as across 
species. Using miRNA microarray profiling of HDL-miRNA 
complexes, healthy human subjects in regular contact with different 
domesticated animals were demonstrated to possess different 
HDL-miRNA profiles that clustered based on the type of animal 
they were in contact with. (35) Furthermore, the differentially 
abundant miRNA species were shown to differentially regulate the 
pro-inflammatory NFκB pathway in cultured human macrophages, 
(35) contentiously suggesting that the type of animal one regularly 
contacts could influence one’s susceptibility to inflammation.
Conclusion
With comparable numbers of protein coding genes spanning the 
evolutionary tree from simple worms to humans, complexity 
is now believed to reside largely in the non-coding part of the 
genome previously dismissed as junk DNA or transcriptional noise. 
Unravelling the intricacies of this vast RNA underworld has already 
revealed numerous pathophysiological mechanisms, only a handful 
of which are presented here. To date, the role of some newly 
defined ncRNA classes, e.g. agotrons, (36) extra-coding RNAs 
(37) and enhancer RNAs (38) remains poorly characterised, which, 
together with the likely prospect of more ncRNA species still to 
be defined, heralds a profuse expansion of the newly (re)discovered 
layer of gene regulation and potential therapeutic applications.
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Figures
Figure 1: miRNA biogenesis and mode of action(39).
Reprinted by permission from Springer Nature: Nature Reviews 
Neuroscience (microRNAs at the synapse, Schratt G.), Copyright 
2009.
Figure 2: miR-125a stabilises iTreg cells and prevents their 
transition into pro-inflammatory TH17-like exTreg cells (adapted 
from(40)).
Reprinted by permission from Springer Nature: Nature Reviews 
Immunology (Interplay between the TH17 and TReg cell lineages: 
a (co-)evolutionary perspective, Weaver CT., and Hatton RD.), 
Copyright 2009.
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Skin picking disorder: what 
can we learn from such a 
topical issue?
Summary
Skin picking disorder (SPD) is a psychodermatological condition characterised by 
repeated pathological picking of the skin, creating recalcitrant excoriated skin lesions. 
As well as the physical manifestations of skin picking, SPD carries with it a host of 
debilitating social, psychiatric and medical sequelae, which greatly impairs quality of 
life in sufferers. It is clinically challenging to make an accurate diagnosis of SPD and, in 
our experience, successful management requires a sensitive and holistic biopsychosocial 
approach involving a psychodermatology multidisciplinary team. 
Relevance
The prevalence of SPD is ~2-4%, yet fewer than 20% of sufferers feel that their clinician 
‘knew much’ about their condition. This must be immensely frustrating for sufferers, 
and it chimes with research suggesting that medical students, and by extrapolation 
doctors, have multiple gaps in their knowledge of psychiatric disorders, patients and 
treatments. We believe that a greater emphasis on psychiatry in medical training is long 
overdue, particularly to highlight the crucial importance of addressing psychosocial 
factors alongside physical symptoms in all patients. 
Take Home Messages
1. SPD is an under-diagnosed and often poorly managed condition that is associated 
with clinically significant distress or impairment in multiple areas of day-to-day 
functioning. 
2. Given the wide differential diagnosis for SPD, a careful history, physical and mental 
state examination is critical in making an accurate diagnosis.
3. SPD lacks a standardised treatment protocol, but successful management can be 
achieved through involvement of a psychodermatology multidisciplinary team.
4. Psychosocial illness is poorly understood by the typical medical undergraduate. 
Medical schools must strive to remedy this by placing a greater emphasis on the 
importance of holistic assessment and treatment in all patients. 
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Skin picking disorder (SPD) is a psychodermatological condition 
reported in medical literature from as early as 1875. (1) The disorder 
is characterised by repeated pathological picking of the skin to 
the extent where lesions are apparent across accessible sites such 
as the face, neck, arms and scalp. SPD carries with it a host of 
extremely debilitating social, psychiatric and medical sequelae, and 
as such, greatly impedes quality of life in sufferers.  
Despite historical recognition of SPD and its serious complications, 
the disorder only became officially recognised in the Diagnostic and 
Statistical Manual of Mental Disorders (DSM-V) in 2013. The exact 
aetiopathogenesis underpinning SPD remains unclear, but the 
evidence implicates both genetic and environmental components. 
(2) Rodent models have identified some candidate genes, which 
appear to converge on dysregulation in the neural circuitry involved 
in habit generation and top-down motor inhibitory control 
processes. (1)
Picking behaviours vary within and between sufferers but are 
typically highly ritualised, and triggered by stress, anxiety or 
boredom. Patients also report feelings of mounting tension prior 
to picking, with relief and even pleasure experienced during or 
immediately afterwards.  The psychosocial component of SPD 
is severe, with many sufferers avoiding daily activities that may 
expose their skin such as work, sport and social commitments.  The 
isolation that follows compounds the problem further by allowing 
more time for skin hypervigilance, picking and unfortunately 
frequent suicidal ideation.  Medical sequelae include bleeding, 
localised infection, septicaemia, scarring and, in the most severe 
cases, an increased risk of mortality warranting neurosurgical 
intervention. (3) 
From the clinician’s point of view, the priority in assessing patients 
with possible SPD is to actively exclude a primary organic disorder.  
Systemic causes of pruritus must be ruled out, such as iron 
deficiency anaemia, diabetes mellitus and coeliac disease.  Primary 
organic dermatoses such as scabies, as well as other related yet 
distinct psychodermatological conditions e.g. dermatitis artefacta, 
must also be distinguished. There is also the challenge of separating 
SPD from common psychiatric co-morbidities that may better 
explain the skin picking.  These include body dysmorphic disorder 
and psychotic disorders involving skin-related delusions and tactile 
hallucinations.  In light of this, a mental state examination is crucial 
to making an accurate diagnosis.
SPD currently lacks a standardised approach to management.  
Evidence in the literature demonstrates a significant benefit for 
behavioural, but not pharmacological therapies, as compared to 
placebo. (4) Skin directed therapies should always be employed 
in conjunction with psychiatric or psychological treatments for 
dual purpose: to treat infection or dry skin if indicated, but also 
to reassure patients unwilling to consider psychosocial factors that 
their problem is being taken seriously.  In our experience, successful 
management requires a sensitive and holistic approach that, looking 
forward, may best be delivered in a specialist multidisciplinary 
psychodermatological clinic. 
The prevalence of SPD is ~2-4%, however, studies have revealed 
that less than 20% of afflicted patients felt that their clinician ‘knew 
much’ about their condition. (4,5) Whilst this must be frustrating 
for sufferers, it also raises a myriad of questions surrounding medical 
education.
Medical students are all too familiar with the endless lists of rare 
mutations that lead to conditions never-to-be-seen on the wards. 
Studies have found that medical students have multiple lacunae 
in their knowledge toward psychiatric disorders, patients and 
treatments. (6) This both fits with the aforementioned issues with 
SPD and is something that medical students experience throughout 
their studies.
There is a complex interplay between psychiatry and the medical 
and surgical specialties that all practitioners need to be aware of. 
Failing to understand this dynamic is a compromise of one’s duty 
of care, and creates a potential hazard for our patients. A simple 
example of this lies with individuals who attend A&E with self-
harm injuries. Patients are often labelled as ‘frequent flyers’ and it is 
unfortunately accepted throughout the literature that analgesia is 
rarely offered, with one patient being told ‘I thought you liked pain’. 
(7) This represents a physical manifestation of psychiatric disease 
and the poor treatment of these patients likely represents poor 
understanding of the full clinical picture, as discussed above with 
SPD. 
Medical students depend on their education to build a career that 
needs to be fundamentally safe and improve the lives of patients. 
It is the joint responsibility of both students and their seniors to 
acknowledge the importance of these newly classified disorders. 
We therefore deserve autonomy over the content of our education. 
Whilst we acknowledge that there are mounting pressures on 
medical education, we suggest the following moving forward: 
• A greater emphasis on psychiatry, including niche disorders that 
are commonly overlooked in typical undergraduate programs. 
• Considering the feasibility of psychiatry as a compulsory 
component in the foundation program. 
• Medical schools to place greater emphasis on the uses and 
benefits of cognitive and behavioural therapies. 
It is our hope that consideration of the above will raise awareness of 
some of the pitfalls that we face as the new generation of medical 
professionals. It must be frustrating for patients who often have 
no choice through which lens we view their disease. We believe 
a holistic biopsychosocial approach should be promulgated in all 
patients to a greater or lesser extent, to ensure that organic disease 
is not missed, and that psychosocial illness is given the credence it 
35
deserves. 
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Clinical Coding - an insight 
into healthcare data
Summary
Clinical coding is an important function within healthcare informatics.  Coding 
datasets have various statistical and clinical uses: a high level of accuracy, completeness 
and specificity is paramount.  Preventable errors can accumulate along the coding 
pathway and may have significant implications for health care management worldwide.
Relevance
Amongst other functions, clinical coding datasets are used for policy creation, clinical 
audit and finance.  Both clinical staff and coding professionals play an equally important 
role in ensuring accurate reporting of hospital activity, but the nature and importance 
of the clinician’s role is often misunderstood and underappreciated.  The coding 
pathway is highly susceptible to human error with clinician-based errors ranging from 
incorrectly defining a clinical entity to underreporting comorbidities.  Clinical staff 
should be aware of the importance of clinical coding, its uses and the role they play in 
ensuring accuracy: a hospital is measured by its output data.  High-quality data leads 
to well-informed service provision, resource allocation and business planning which 
cumulates into enhanced patient outcomes.
Take Home Messages
Errors occurring along the coding pathway can have significant financial and statistical 
ramifications.  Clinicians and coding professionals must work collaboratively to improve 
the quality of healthcare data flows.  Regular engagement between all influential parties 
along the coding pathway is vital, with frequent reviews of clinical documentation and 
coding reports a firm foundation for continual improvement.  Accurate and reliable 
healthcare data supports the optimisation of patient care.
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Introduction
Effective healthcare management requires versatile and pre-emptive 
strategic planning.  For this to be possible, hospitals depend on 
an effective mechanism for data collection, collation and analysis: 
clinical coding.  Clinical coding is the translation of clinical 
statements into alphanumeric codes, typically four characters in 
length. (1)  Its purpose is to standardise the recording of clinical 
information to enable datasets to be analogous. (2) There are 
numerous ways to describe the same clinical entity, so without a 
standardised system these cases could be coded differently, creating 
a barrier to comparable analyses.  In the United Kingdom (UK), 
two classifications are currently used for clinical coding: the 10th 
International Statistical Classification of Diseases and Related 
Health Problems (ICD-10) and the Office of Population Censuses 
and Surveys Classification of Interventions and Procedures version 
four (OPCS-4). (3)
The quality of coding depends on a collaborative approach being 
championed by coders and clinical staff alike. (4)  The value and 
accuracy of clinical coding is particularly important in England 
as coding underpins the National Tariff Payment System (NTPS) 
(formally known as Payment by Results (PbR)). (3)  Under this 
system, provider income flows are directly related to clinical activity. 
As clinical coding is the nationally adopted method to document 
such activity, it is essential that coding datasets are complete, 
accurate and hold the highest possible level of specificity to 
circumnavigate potential financial pitfalls. 
Despite its importance, awareness of clinical coding is low amongst 
junior doctors. (5)  It is essential that all clinical staff understand the 
importance of the role they have to play in refining healthcare data 
flows, as ultimately they determine the usefulness of such data for 
all secondary purposes.
Uses of clinical coding
Clinical coding allows for reliable collation, aggregation and 
comparison of healthcare data on local, national and international 
platforms.
Local uses
Coding data is useful for clinical audit, tracking patient outcomes 
and measuring treatment effectiveness.  It is a means for easily 
identifying specific patient cohorts, tracking complication rates 
and linking outcomes to a defined criteria, such as the surgeon 
performing a procedure or procedural technique adopted.  
Management in a provider setting use coding data for monitoring 
and planning.  Casemix analyses facilitate appropriate resource 
distribution, policy derivation and growth prediction.  Reliable data 
aids clinical governance and encourages good practice. (6)
Under the NTPS, coding datasets are used as a means to reimburse 
providers for the care that they provide.  Inaccuracies can lead to 
signficant financial losses with any one error having the potential of 
being valued in the thousands of pounds. (4) Coding datasets are 
therefore a key component in cost analyses and business planning. 
(7) 
National uses
Monitoring patterns in activity and trends over time allows for 
tailored, region-specific resource planning and allocation.  Coding 
data is widely used by governmental and healthcare bodies to 
monitor, develop and evaluate healthcare policies across the UK. (8) 
National indicators of clinical quality and best practice are tracked 
and reimbursed using specific coding derivatives. (9)
National benchmarking and comparison highlights areas where 
improvement is needed and provides a resource for patients to 
make greater-informed choices about where and how they access 
care. (10, 11)  Discrepancies in coding data help ascertain ‘dead 
zones’ for particular types of care and provide a means for assessing 
fair access to healthcare.
International uses
All World Health Organisation (WHO) members use the ICD. (12) 
This permits monitoring of the aetiology, incidence and prevalence 
of diseases globally and helps identify at risk populations, on the 
basis of diagnostic, demographic or environmental factors. (13)  
International learning models can be derived from shared data 
pools, permitting global collaboration on policy creation and 
resource forecasting.
The clinical coding pathway
From admission to secondary user
Figure 1 outlines the inpatient coding pathway from admission to 
secondary user.  This pathway is specific to secondary and tertiary 
care in England. 
The pathway begins when a patient is admitted to a hospital and 
undergoes treatment or investigation (step 1).  Clinical staff detail 
all of the patient events that occurred throughout the hospital spell 
in the medical record.
Following discharge, clinical coders translate the clinical 
information into codes using ICD-10 and OPCS-4 (step 2).  Providers 
work towards having all activity coded by an initial deadline known 
as ‘flex,’ which gives providers and commissioners the opportunity 
to assess the data and make corrections where appropriate. (14)
Quality assurance analyses are performed to ensure coding 
accuracy and abidance by national standards (step 3).  The 
information governance toolkit is a framework for clinical coding 
audit. Providers must ensure that they have carried out internal 
audits on whichever is smaller of 200 or 2% of total finished 
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consultant episodes (FCEs). (15)  Continual assurance activity 
helps safeguard a precise position for contract monitoring and 
performance regulation (step 4a).
In line with a final deadline known as ‘freeze,’ (14) providers submit 
their coding data to the Secondary Uses Services (SUS+) via 
commissioning datasets (step 4b). (10)  SUS+ is a UK information 
warehouse that stores healthcare data in adherence to national 
policies. (10)  There are different commissioning datasets 
depending on the type of care provided (admitted patient care 
(APC), outpatients (OP), accident & emergency (A&E) etc.). 
Before the data can be accepted by SUS+, it is validated against 
business rules and if this is successful, the data is then passed 
through a grouper software (step 5). (16)  The grouper uses a 
sophisticated algorithm, created by the National Casemix Office, 
to group clinically meaningful clusters of activity. (3)  These groups 
are known as Healthcare Resource Groups (HRGs). (3)  HRGs are 
the currency for remuneration in England and carry a defined 
tariff representative of the care provided with consideration of 
demographic and provider information. (17)  
If processing has been efficacious, the data is made available to 
approved SUS+ users.  There are two data marts: defined layers 
of the data warehouse aligned with user requirements (step 5).  
The Standard Extract Mart (SEM) view shows completed hospital 
episodes without any additional payment-related additions. 
(16)  SEM is used to derive Hospital Episode Statistics (HES) (step 
6a).  HES is an anonymised database containing information of 
all admissions, outpatient appointments and A & E attendances 
in England. (8)  The PbR view shows spell based activity with 
additional payment related derivations (step 6b). (16)  It is used for 
derivation of NTPS policy, monitoring and reimbursement.
Key Roles
The number of ‘influencers’ along the pathway varies with the size 
of a setting and local practice.  Some influential roles are outlined 
below. 
Clinical Coders
Clinical coders perform the act of coding, working in accordance 
with local, national and international guidance to ensure uniformity. 
(13, 18)  Clinical coders have a responsibility to stay up to date with 
changes to these standards as well as local recording protocols.  
They are encouraged to work towards professional registration (19) 
to prove a standard of accuracy.
Clinical Coding Auditors
Coding auditors assure the quality of clinical coding against 
national standards and reporting requirements. (13, 15)  This 
may be done internally within a trust or on behalf of external 
commissioning providers.  
Clinical Staff
All clinical staff have a legal requirement to ensure documentation 
is complete and accurate. (20)  Junior doctors are typically tasked 
with completing discharge summaries, which are a primary source 
of information for coding purposes.
Data Analysts
Data analysts utilise coding datasets for strategic planning, contract 
monitoring and identification of areas for change.
Health Informatics Managers
Informatics managers are tasked with aggregating and submitting 
all commissioning data sets to SUS+.  They work extensively 
with commissioners and other third parties to ensure the correct 
processes, outlined within the NHS standard contract are adhered 
to. (21)
Sources of coding errors 
Estimates on coding accuracy vary drastically, with systematic 
reviews suggesting a median accuracy of around 80%. (22)  
Coder errors
Errors by clinical coders are well reported in the literature and are 
often multifactorial. (17, 22, 23)  The experience of a coder directly 
influences the quality of coding. (23)  A coder’s knowledge about 
the diseases and procedures that they are coding can make the 
difference between separating a symptom of a condition from a 
new finding. (24)  A coder could ‘under-code’ by being unable to 
differentiate between separate clinical entities.  Time restraints, 
the level of coder-clinician communication and departmental 
leadership styles can all affect coding practice. (25)  Failure to clarify 
queries or request missing subsidiary information, such as external 
causes or infection aetiology, can all lead to paucity in coding 
datasets. (17, 26) 
Clinician errors
The eventual value of clinical coding is limited by the quality of 
clinical documentation; electronic discharge summaries have been 
shown to often be suboptimal for coding purposes. (17)  Junior 
doctors receive minimal education on clinical coding, (27) and are 
typically first introduced to the topic at local hospital inductions. 
In general, this is ineffective and, despite a willingness to engage 
with the field, clinicians often fail to adequately meet all coding 
requirements when recording clinical events. (5)  A lack of a robust 
educational programme has meant that misconceptions on the 
uses and importance of clinical coding are rife, and many clinical 
staff members are uncertain as to what is required from them. (5, 
26)
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Lack of engagement, between clinical staff and coding 
professionals, has been correlated with significant financial 
repercussions and omission of noteworthy information. (4, 26)  A 
lack of specificity frequently causes difficulties with different codes 
available as subcategories of the same disease or morbid entity.  An 
example of this is the coding of obesity.  In ICD-10, obesity (with no 
further modifiers) is coded as E66.9 – Obesity, unspecified whereas 
morbid obesity and drug-induced obesity are coded with E66.8 – 
Other obesity and E66.1 – Drug-induced obesity respectively. (12)  
In some cases, the clinical management of the conditions defined 
by ICD-10 subcategories does not change, so from a medical 
perspective the ‘unspecified’ description of a condition may be 
deemed sufficient to ensure continuity of care. (28)  Idiosyncratic 
use of abbreviations, inconsistencies between the ways clinicians 
document patient events and failure to record information in a 
predictable structure, all create interpretational dilemmas for the 
coder. (4)  
Under the current version of the NTPS, inpatient tariffs can be 
affected by a patient’s summed ‘comorbidity score’; correct 
financial reimbursement is reliant on all relevant secondary 
diagnoses and comorbidities being coded. (3) Failure to record 
that conditions have been fully treated or resolved can inhibit the 
correct ‘history of’ codes being assigned and requires the coder 
to dedicate significant resources towards determining whether a 
condition is current.  Coders cannot infer test results and require a 
definitive interpretation of radiological, biochemical, histological 
and microbiological results. (13)  This interpretation must be 
made by the clinician and documented in the medical record, 
especially in cases where the patient is treated on the basis of these 
investigations.  The nature of acute injuries should be recorded to 
ascertain the circumstances in which the injury arose, to permit 
injury surveillance. (29)
Methods for reducing clinical coding errors
The first step in reducing the likelihood of coding errors occurring 
is raising awareness of regularly reported problems.  With increased 
awareness, it is possible to introduce subtle changes in local practice 
to best serve both clinical and administrative functions. Table 1 
outlines a framework for mitigating the effects of common pitfalls.
The future of clinical coding
The field of clinical coding is rapidly evolving and there is plenty 
of debate about future directions. (2) The implementation 
of Systematized Nomenclature of Medicine–Clinical Terms 
(SNOMED CT), which is a structured terminology within an 
Electronic Patient Record (EPR), (31) will permit ICD-10 and 
OPCS 4.8 to be cross mapped directly to clinical documentation 
rather than coded by a coding professional.  As such, the roles of the 
clinician and coder will continue to transform over time.
Conclusion
It is essential that all influential parties, along the coding pathway, 
work coherently to ensure healthcare data is complete, accurate 
and reliable.  Sources of error are plentiful but ill effects can be 
diminished or lessened with diligence and planning.  Education is 
the key to improvement and more must be done to raise awareness 
if we are to continue to use clinical coding for essential secondary 
functions.
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Error Owner Potential solution(s)
Lack of specificity Clinical staff
•	 Be as specific as possible when documenting diagnoses (e.g. link re-
sults, use multiple descriptors) and procedures (e.g. site, laterality, 
method of approach).
•	 Liaise with coders to establish the descriptions required for accurate 
code assignment.
Use of 
abbreviations Clinical staff
•	 Record diagnoses and procedures using the full ICD-10/OPCS 4 de-
scriptions.
•	 If an abbreviation must be used provide a reference key for clarifica-
tion.
Omitted 
comorbidities
Clinical staff
•	 Record all comorbidities in all primary source documentation (e.g. 
clinic letters, discharge summaries).
•	 Use service specific tick sheets to identify commonly missed comor-
bidities.
•	 Engage in regular coding audits.
•	 Develop and engage with new internal IT systems to promote comor-
bidity capture.
Unclear primary 
diagnoses 
or reason for 
admission
Clinical staff
•	 Record a patient’s primary diagnosis clearly following any local pro 
forma standards. 
•	 If no definitive diagnosis can be made, record all of the patient’s 
signs, symptoms or abnormal finding. 
•	 If there are no signs and symptoms, describe the reason for encoun-
ter (e.g. follow up after surgery or screening due to a family history 
of a condition).
Missing 
procedures/
interventions
Clinical staff
•	 Ensure that any procedures/interventions are fully described includ-
ing those that may have been completed on the ward.
•	 Record the dates procedures/interventions took place.
•	 Engage in regular coding audits.
Ambiguous past 
medical history
Clinical staff
•	 Make a clear distinction between a condition that has been fully 
treated or resolved and one which is ongoing. 
•	 Follow local pro forma protocols.
Use of suboptimal 
language Clinical staff
•	 Refrain from using terms such as “likely,” “suggestive of” and “im-
pression” that cannot be used for clinical coding. 
•	 Instead, use phrases such as “probable,” “working diagnosis” and 
“treated as.”
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Absent linkages 
between results 
and disease status
Clinical staff
•	 Link all results to a condition (e.g. microbiology, histology, radiology 
etc.).
•	 If results are not available at the time of discharge, document that 
they are pending.
•	 Review test results and amend the discharge documentation where 
appropriate.
•	 Engage in regular coding audits.
Unclear timelines Clinical staff
•	 Record date and times of ward/clinician transfers.
•	 Record dates when procedures were performed or complications 
arose.
Lack of 
engagement
Clinical staff/ 
Coder
•	 Participate in audits and assurance exercises.
•	 Encourage wider partaking in coding events and workshops.
Inappropriate code 
assignment
Coder
•	 Attend frequent training to refresh knowledge of the national stan-
dards. (13, 18)
•	 Clarify any ambiguous clinical information with responsible clinicians.
Not keeping up 
to date with new 
coding standards
Coder
•	 Read and update classifications with the latest coding standards and 
coding clinics. (13, 18, 30)
Lack of experience Coder
•	 Undertake coding for different specialties 
•	 Attend all refresher courses and training workshops (where relevant).
Table 1: Methods for reducing coding errors
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Medical students are often hard to find on the wards after 3.00pm. In 
this reflective piece, using our own experiences of clinical teaching we 
describe the case of an archetypal, and stereotypical medical student 
who rarely attends a full day of timetabled clinical teaching. Using this 
case as an example we outline our insights of the reasons underpinning 
the fact many medical students leave clinical teaching placements well 
before 5.00pm, and in doing so miss out of learning opportunities. 
We also make two simple recommendations to medical students and 
teachers that could be employed to incentivise students to linger longer 
on their clinical placements. 
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Introduction 
Medical school is a challenge, and developing the clinical skills and 
understanding to become an excellent doctor requires dedication, 
perseverance and lots of practice. 
Being a doctor appears to be even more challenging, with 
long working hours, and without the luxuries of time, lack of 
accountability, and opportunities to go home at 2.30pm commonly 
afforded to medical students. 
Students become increasingly aware of two contrasting choices 
whilst at clinical school: a choice to commit more time to clinical 
education in order to thrive as a junior doctor, and a choice to 
commit more time to social life and take all opportunities to avoid 
staying late in hospital whilst it is possible. 
Here we describe the case of the vanishing medical student, analyse 
factors contributing to their regular disappearance and suggest 
strategies to incentivise students to commit more time to clinical 
education.
Case presentation 
Mr X is a 22-year-old archetypal, stereotypical medical student in the prime 
of his student life. He presented insidiously over 2 years with afternoons 
off syndrome, which is now so severe he has only stayed on the wards after 
2.30pm once in the last 3 months. This is on a background of feeling like a 
spare part on the ward, minimal formalised ward-based teaching sessions, and 
recommendations by ward staff to “enjoy being a student while you can”.
He has an interesting past medical history with lots of exposure to clinical 
specialties during his work experience, volunteering in a hospitals abroad and 
had dreams of becoming a cardiac surgeon from a young age. 
Currently he lives in a student flat, is a non-smoker and has a mild Netflix 
addiction. 
Mr X is untroubled by his condition as he feels he will “learn most of 
it [clinical medicine] on the job”. He also claims he uses his afternoons 
practicing for objective structural clinical exams (OSCEs) or reading in 
the library in order to prepare for exams, working on audits to develop his 
curriculum vitae (CV) as well as rewatching season one of Game of Thrones. 
He has attempted one cannula in the last two years and was unsuccessful – 
none of his flat mates have attempted one. 
Discussion
This common case highlights many issues that contribute to the 
regular disappearance of many medical students from clinical 
training.
Importantly, junior doctors are becoming increasingly demoralised 
and this has direct implications for their own teaching and the 
teaching of medical students. (1) Not only are junior doctors 
workloads restricting the amount of time they can dedicate to 
teaching students, (1) observing exhausted, stressed, and busy junior 
doctors on the wards encourages some students to leave early and 
make the most of having minimal responsibility while they can. 
This is not helped by the fact students are regularly asked something 
along the lines of  ‘why are you here, its 3.00pm?’ or told ‘there is 
not much going on, I would just take the afternoon off.’
Students avoiding the wards creates a vicious cycle: by not 
attending, students fail to develop trusting relationships with 
the teams - this means when they are about they are given less 
responsibility and opportunities to practice, and often feel like spare 
parts – this means they are less likely to attend.  
Additionally, as observed in the case above, examination systems at 
medical schools do not always incentivise students to spend more 
time on the wards. 
Recommendations 
We recommend two practical solutions for managing cases of 
vanishing students. Firstly, students should spend week one of a 
new rotation committing fully and getting to know the ward team, 
breaking the vicious cycle described above and increasing future 
learning opportunities and student satisfaction. 
Secondly, as undertaken in some UK teaching hospitals, students 
should be assigned to individual patients on the ward. Students 
would then be responsible for presenting their patients on the 
morning ward rounds and assisting with any procedure and tests 
being performed. Furthermore, when other opportunities for 
learning are lacking, rather than escaping home, students can 
spend time talking to their selected patients. This should encourage 
students to spend more time on the wards, allow them to follow the 
elusive ‘patient journey’ and provide an opportunity for students to 
play a key role in making a patient feel better – which, as mentioned 
on all student’s personal statements, is a motivating factor driving 
them to join the medical profession.  
We believe using these steps, as well as encouraging professionalism 
among students, should help students to choose to commit more 
time to clinical education in order to thrive as a junior doctor.
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